ABT Abbott Laboratories

  1. Stocks
  2. Healthcare
  3. NYSE: ABT

Price (delayed)

$90.76

Market cap

$158.09B

P/E Ratio

25.28

Dividend/share

$2.44

EPS

$3.59

Enterprise value

$185.33B

?
Relative Growth: Rel. Growth: 38
Relative Strength: Rel. Strength: 13
Relative Valuation: Rel. Valuation: 48
Relative Profitability: Rel. Profitability: 64

Abbott Laboratories is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois, United States. The company was founded by Chicago physician Wallace Calvin Abbott ...

Highlights
ABT's P/E is 13% below its 5-year quarterly average of 28.0
ABT's equity is up by 7% year-on-year
Abbott Laboratories's debt has surged by 163% QoQ and by 157% YoY
Abbott Laboratories's net income has shrunk by 54% YoY and by 3.8% QoQ
Sector: Healthcare
Industry: Medical Devices
Website: https://www.abbott.com
Peers: JNJ PFE MDT TMO

Key stats

What are the main financial stats of ABT

ABT stock price

How has the Abbott Laboratories stock price performed over time
Intraday
3.34%
1 week
0.15%
1 month
3.83%
1 year
-31.89%
YTD
-27.56%
QTD
-11.6%

Financial performance

How have Abbott Laboratories's revenue and profit performed over time
Revenue
$45.13B
Gross profit
$25.39B
Operating income
$7.71B
Net income
$6.28B
Gross margin
56.3%
Net margin
13.9%
Abbott Laboratories's net margin has shrunk by 56% YoY and by 5% QoQ
Abbott Laboratories's net income has shrunk by 54% YoY and by 3.8% QoQ
The operating income has grown by 8% YoY but it has contracted by 4.3% from the previous quarter
The gross profit has increased by 7% year-on-year

Price vs fundamentals

How does ABT's price correlate with its fundamentals

Growth

What is Abbott Laboratories's growth rate over time

Valuation

What is Abbott Laboratories stock price valuation
ABT P/E details
P/E
25.28
P/B
2.99
P/S
3.5
EV/EBIT
21.37
EV/EBITDA
15.66
EV/Sales
4.11
The EPS has plunged by 53% YoY and by 3.8% from the previous quarter
ABT's P/E is 13% below its 5-year quarterly average of 28.0
ABT's price to book (P/B) is 42% lower than its 5-year quarterly average of 5.0 and 31% lower than its last 4 quarters average of 4.2
ABT's equity is up by 7% year-on-year
ABT's P/S is 31% below its last 4 quarters average of 4.9 and 28% below its 5-year quarterly average of 4.7
The revenue has grown by 7% YoY

Efficiency

How efficient is Abbott Laboratories business performance
Abbott Laboratories's return on assets has shrunk by 60% YoY and by 12% QoQ
ABT's ROE has plunged by 60% YoY and by 5% from the previous quarter
The ROIC has contracted by 13% from the previous quarter and by 13% YoY
The ROS has contracted by 5% from the previous quarter but it has grown by 2.7% YoY

Dividends

What is ABT's dividend history
Dividend details
DPS
$2.44
Dividend yield
2.69%
Payout ratio
68%
Recent dividends

Special dividends are included in TTM DPS and yield

Financial health

How did Abbott Laboratories financials performed over time
The total assets is 91% more than the total liabilities
Abbott Laboratories's total liabilities has soared by 78% YoY and by 70% from the previous quarter
The total assets has grown by 36% YoY and by 27% from the previous quarter
Abbott Laboratories's debt is 35% lower than its equity
Abbott Laboratories's debt has surged by 163% QoQ and by 157% YoY
Abbott Laboratories's debt to equity has soared by 160% from the previous quarter and by 141% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.